SFA Therapeutics

About:

SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.

Website: https://sfatherapeutics.com

Top Investors: Y Combinator, Ben Franklin Technology Partners of Southeastern Pennsylvania, Boost VC, Acequia Capital (AceCap), Asymmetry Ventures

Description:

SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.

Total Funding Amount:

$8.73M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jenkintown, Pennsylvania, United States

Founded Date:

2016-01-01

Contact Email:

ira.spector.sfatherapeutics(AT)gmail.com

Founders:

Alla Arzumanyan, Ira Spector, Mark Feitelson

Number of Employees:

1-10

Last Funding Date:

2023-11-09

IPO Status:

Private

Industries: